Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Milano

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Plos One|February 14, 2022
Increased risk of high-grade prostate cancer among testicular cancer survivorsHong Zhang, Hongmei Yang, Sanjukta Bandyopadhyay, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastasesAlan W Katz, Madeleine Carey-Sampson, Ann G Muhs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based StudyChunkit Fung, Sophie D Fossa, Michael T Milano, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Stereotactic body radiotherapy for treatment of adrenal metastasesSheema Chawla, Yuhchyau Chen, Alan W Katz, et al.
Cancer Treatment Reviews|March 14, 2003
Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive reviewJohnny Kao, Michael C Garofalo, Michael T Milano, et al.
Cancer|July 21, 2011
Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patientsHong Zhang, Lois B Travis, Rui Chen, et al.
Radiology|June 10, 2010
Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastomaRajiv Mangla, Gurshawn Singh, Doerthe Ziegelitz, et al.
Frontiers in Oncology|January 7, 2014
Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 MenHong Zhang, Edward M Messing, Lois B Travis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survivalSughosh Dhakal, Kimberly S Corbin, Michael T Milano, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancerJoseph K Salama, Daniel J Haraf, Kerstin Stenson, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Plos One|February 14, 2022
Increased risk of high-grade prostate cancer among testicular cancer survivorsHong Zhang, Hongmei Yang, Sanjukta Bandyopadhyay, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastasesAlan W Katz, Madeleine Carey-Sampson, Ann G Muhs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based StudyChunkit Fung, Sophie D Fossa, Michael T Milano, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Stereotactic body radiotherapy for treatment of adrenal metastasesSheema Chawla, Yuhchyau Chen, Alan W Katz, et al.
Cancer Treatment Reviews|March 14, 2003
Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive reviewJohnny Kao, Michael C Garofalo, Michael T Milano, et al.
Cancer|July 21, 2011
Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patientsHong Zhang, Lois B Travis, Rui Chen, et al.
Radiology|June 10, 2010
Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastomaRajiv Mangla, Gurshawn Singh, Doerthe Ziegelitz, et al.
Frontiers in Oncology|January 7, 2014
Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 MenHong Zhang, Edward M Messing, Lois B Travis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survivalSughosh Dhakal, Kimberly S Corbin, Michael T Milano, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancerJoseph K Salama, Daniel J Haraf, Kerstin Stenson, et al.
Pageof 17